ArticleAnnals of medicine and surgery (2012)2025
Advanced biomaterials and virtual reality for interventions in rare episodic cluster headache mimicking SUNCT syndrome: emerging directions in precision pain management.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rare episodic cluster headache mimicking SUNCT syndrome presents a unique clinical challenge due to overlapping trigeminal autonomic features and limited therapeutic efficacy of conventional interventions. Recent innovations in advanced biomaterials, such as poly(L-lactic acid) and PVDF-based piezoelectric scaffolds integrated with decellularized extracellular matrix, offer biocompatible platforms for trigeminal nerve repair and inflammation modulation. Virtual reality (VR) technologies, through immersive pain-modulation environments, enhance neuroplasticity and empower patients in real-time symptom control. Artificial intelligence (AI) algorithms, incorporating multi-omic and wearable sensor data, enable personalized trigger profiling, predictive prevention, and early attack forecasting. CRISPR-based gene-editing strategies targeting pain-modulating genes, such as TACR1, have demonstrated potential in preclinical models for refractory headache management. Integrating these multidisciplinary innovations into clinical frameworks may pave the way for precision pain medicine, improved patient self-management, and enhanced long-term outcomes for those suffering from this debilitating headache disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.